Latest Earnings Released (Q3 FY25): Reported quarterly statutory revenue of ₹293.63 Cr with net profit of ₹15.01 Cr (EPS: ₹3.96).
Exchange Disclosure (2026-08-20): Monitoring Agency Report — Monitoring Agency Report for the quarter ended June 30, 2026 — Monitoring Agency Report for the quarter ended June 30, 2026
Official listing profile for Gensol Engineering Ltd under Diversified.
Official listing profile for Gensol Engineering Ltd under Diversified.
Diversified
- Strong YoY revenue expansion (147.2%)
- High net earnings expansion (202.1%)
- Multi-year compound top-line expansion sustained over 3+ years
- Superior Return on Equity (25.7%)
- Robust operating profitability margin (31.1%)
- High financial leverage: Debt/Equity exceeds 1.5x (4.46x)
- Tight interest coverage safety buffer (1.4x)
- Negative operating cash flow reported in latest fiscal period
- Negative Free Cash Flow absorbed by heavy capital expenditure
| Annual Metric (₹ Cr) | FY20 Mar 2020 | FY21 Mar 2021 | FY22 Mar 2022 | FY23 Mar 2023 | FY24 Mar 2024 |
|---|---|---|---|---|---|
| Sales / Revenue from Operations | ₹77 | ₹60 | ₹154 | ₹366 | ₹904 |
| Operating Expenditure | ₹76 | ₹57 | ₹141 | ₹326 | ₹764 |
| Operating Profit (EBITDA) | ₹0.82 | ₹3.48 | ₹13 | ₹40 | ₹140 |
| Operating Profit Margin (OPM %) | 6.68% | 9.18% | 12.79% | 17.03% | 31.09% |
| Other Income | ₹2.83 | ₹0.72 | ₹2.34 | ₹7.44 | ₹40 |
| Finance Costs / Interest | ₹1.47 | ₹1.32 | ₹4.72 | ₹15 | ₹101 |
| Depreciation & Amortization | ₹0.51 | ₹0.58 | ₹0.59 | ₹11 | ₹72 |
| Profit Before Tax (PBT) | ₹3.14 | ₹3.62 | ₹14 | ₹36 | ₹108 |
| Tax Expense | ₹-0.98 | ₹-0.50 | ₹-3.30 | ₹-9.34 | ₹-28 |
| Net Profit (PAT) | ₹2.16 | ₹3.12 | ₹11 | ₹27 | ₹80 |
| Net Profit Margin (NPM %) | 2.82% | 5.19% | 7.18% | 7.28% | 8.90% |
| Basic / Diluted EPS (₹) | ₹3.05 | ₹3.80 | ₹10.08 | ₹23.00 | ₹21.35 |
| Cash from Operations (CFO) | N/A | N/A | N/A | N/A | ₹-98 |
| Free Cash Flow (FCF) | N/A | N/A | N/A | N/A | ₹-577 |
| Quarterly Metric (₹ Cr) | Q3 FY24 Dec 2023 | Q4 FY24 Mar 2024 | Q1 FY25 Jun 2024 | Q2 FY25 Sep 2024 | Q3 FY25 Dec 2024 |
|---|---|---|---|---|---|
| Sales / Revenue | ₹201 | ₹363 | ₹275 | ₹299 | ₹294 |
| Operating Profit (EBITDA) | ₹35 | ₹55 | ₹67 | ₹53 | ₹19 |
| OPM % | 36.75% | 28.21% | 32.70% | 37.89% | 14.45% |
| Profit Before Tax (PBT) | ₹23 | ₹47 | ₹43 | ₹51 | ₹18 |
| Net Profit (PAT) | ₹18 | ₹35 | ₹33 | ₹46 | ₹15 |
| NPM % | 8.72% | 9.59% | 11.82% | 15.48% | 5.11% |
| Basic / Diluted EPS (₹) | ₹4.66 | ₹9.24 | ₹8.59 | ₹12.21 | ₹3.96 |
| Balance Sheet Item (₹ Cr) | FY20 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Equity Share Capital | N/A | N/A | N/A | ₹12 | ₹38 |
| Reserves & Surplus | N/A | N/A | N/A | N/A | ₹288 |
| Net Worth (Shareholders' Funds) | N/A | N/A | N/A | N/A | ₹313 |
| Total Borrowings & Debt | N/A | N/A | N/A | N/A | ₹1,397 |
| Total Balance Sheet Assets | N/A | N/A | N/A | N/A | ₹2,328 |
| Cash Flow Item (₹ Cr) | FY20 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities (CFO) | N/A | N/A | N/A | N/A | ₹-98 |
| Cash Flow from Investing Activities (CFI) | N/A | N/A | N/A | N/A | ₹-667 |
| Cash Flow from Financing Activities (CFF) | N/A | N/A | N/A | N/A | ₹859 |
| Free Cash Flow / Net Cash Flow | N/A | N/A | N/A | N/A | ₹-577 |
| Financial Ratio / Efficiency Metric | FY20 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Operating Profit Margin (OPM) | 6.68% | 9.18% | 12.79% | 17.03% | 31.09% |
| Net Profit Margin (NPM) | 2.82% | 5.19% | 7.18% | 7.28% | 8.90% |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | 25.71% |
| Return on Capital Employed (ROCE) | N/A | N/A | N/A | N/A | 12.20% |
| Return on Assets (ROA) | N/A | N/A | N/A | N/A | 3.46% |
| Debt to Equity Ratio | N/A | N/A | N/A | N/A | 4.46x |
| Interest Coverage Ratio | 0.6x | 2.6x | 2.7x | 2.6x | 1.4x |
| CFO to Net Profit Conversion | N/A | N/A | N/A | N/A | -1.22x |
| Type | Ex-Date | Record Date | Amount / Ratio | Description |
|---|---|---|---|---|
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹2.00 | Final Dividend - Rs. - 2.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹7.00 | Final Dividend - Rs. - 7.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.50 | Final Dividend - Rs. - 0.5000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹5.00 | Final Dividend - Rs. - 5.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.55 | Final Dividend - Rs. - 0.5500 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹25.00 | Final Dividend - Rs. - 25.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹3.00 | Final Dividend - Rs. - 3.0000 |
| CORPORATE_ACTION | 2026-09-15 | 2026-09-15 | N/A | Right Issue of Equity Shares |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹1.00 | Final Dividend - Rs. - 1.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.30 | Final Dividend - Rs. - 0.3000 |
Monitoring Agency Report for the quarter ended June 30, 2026
The Exchange has sought clarification from Gensol Engineering Limited with respect to recent news item captioned IREDA declares Rs 673 crore Gensol loans as fraud; reports to RBI. The response from the Company is attached.
The Exchange has sought clarification from Gensol Engineering Limited with respect to recent news item captioned IREDA declares Rs 673 crore Gensol loans as fraud; reports to RBI. The response from the Company is awaited.
Monitoring Agency Report
Gensol Engineering Limited has informed the Exchange regarding Change in Auditors of the company.
Public announcement has been made by IRP in form A on 16
Gensol Engineering Limited has informed the Exchange about Corporate Insolvency Resolution Process
The Exchange has sought clarification from Gensol Engineering Limited with respect to recent news item captioned Gensol Engineering shares slide 5%, extending 20-day rout after SAT denies interim relief. The response from the Company is attached.
Final Dividend - Rs. - 2.0000
Final Dividend - Rs. - 7.0000
Final Dividend - Rs. - 0.5000
Final Dividend - Rs. - 5.0000
Final Dividend - Rs. - 0.5500
Final Dividend - Rs. - 25.0000
Final Dividend - Rs. - 3.0000
Right Issue of Equity Shares
Final Dividend - Rs. - 1.0000
Final Dividend - Rs. - 0.3000
Final Dividend - Rs. - 2.0000
Final Dividend - Rs. - 7.0000
Every financial metric, balance-sheet balance, and shareholding breakdown displayed on this dossier is grounded in primary statutory filings submitted to Indian stock exchanges (SEBI LODR Regulations 31, 33, and 47). No data is manufactured, estimated, or interpolated.
| Data Domain | Reporting Period | Statutory Source | Ingestion Date | Status | Provenance Hash |
|---|---|---|---|---|---|
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 03 Nov 2026, 02:32 | VERIFIED | 9b9777091da1... |
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 30 Oct 2026, 16:32 | VERIFIED | 423abff89a03... |
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 28 Oct 2026, 00:43 | VERIFIED | 713792637420... |
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 25 Oct 2026, 03:26 | VERIFIED | b15fca985a24... |
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 21 Oct 2026, 03:45 | VERIFIED | 8359b2d882fe... |
| financials_quarterly | SCHEDULED_CHECK | NSE_OFFICIAL_API | 16 Oct 2026, 18:45 | VERIFIED | 7fd18536f70b... |
DATA SOURCES, STATUTORY DISCLOSURES & METHODOLOGY
All corporate identifiers, listed equity data, shareholding patterns, and financial statements are extracted from official regulatory authorities: National Stock Exchange of India (NSE), BSE Limited, and Ministry of Corporate Affairs (MCA) via audited XBRL Ind-AS submissions under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations 31, 33, and 47). Data is ingested and archived on official end-of-day (EOD) schedules with immutable provenance tracking.
Zero-Fabrication Policy: SRK Money Talk strictly enforces authentic data integrity. No financial values, debt levels, cash flows, or quarterly earnings are ever mathematically synthesized, interpolated, or fabricated. When statutory disclosures have not yet been filed or ingested, fields are strictly labeled as N/A or NOT_YET_AVAILABLE.
Statutory Disclaimer: The SRK Fundamental Health Score is a quantitative diagnostic algorithm based exclusively on historical audited filings and does not constitute an investment recommendation or financial advisory. Always consult a SEBI-registered investment adviser before making capital allocation decisions.